Experiment 1139324
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | RAUWS,AG: OLLING,M: TIMMERMAN,A:. (1982). THE PHARMACOKINETICS OF PRUNASIN, A METABOLITE OF AMYGDALIN.. 19(8) |
| Amount utilized | |
| Compound isolated | |
| Disease | DISTRIBUTION PHASE ALPHA HALF LIFE IS 0.07-0.09 HRS, THE ELIMINATION PHASE BETA HALF LIFE IS 0.630.66 HRS. DISTRIBUTION RATE CONSTANTS ARE K12 (1/H) 1.00-1.82 AND K21 (1/H) 4.67-4.96. THE ELIMINATION RATE CONSTANT IS 1.41-1.54 VOLUMES OF DISTRIBUTION ARE CENTRAL 0.33-0.35, BETA 0.50-0.52. PLASMA CLEARANCE 0.54-0.55. AREAS UNDER THE PLASMA CONCENTRATION CURVE ARE 15.57-17.15 (MG(H.L)) FOR IV ADMINISTRATION AND 7.53-8.75 FOR ORAL ADMINISTRATION. ABSOLUTE AVAILABILITY IS 48-51%. |
| Dose amount | 10.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | DOG |
| Per unit | KG |
| Dose expression | DOSE |